An ADP-ribosyltransferase was found in elongation factor 2 (EF-2) preparations from polyoma virustransformed baby hamster kidney (pyBHK) cells. Like Mono(ADP-ribosyl)ated proteins have been found in a variety of eukaryotic tissues (1-3). These ADP-ribosylated proteins are present in practically every major compartment of the cell (4), suggesting a diversity of biological functions. However, little is known about the identity of these mono-(ADP-ribosyl)ated acceptor proteins and their physiological functions. Moss and Vaughn (5) have described a cytosolic ADP-ribosyltransferase from turkey erythrocytes that catalyzes the mono(ADP-ribosyl)ation of several endogenous proteins and the activation of brain adenylate cyclase. They were the first to suggest that the ADP-ribosyltransferase mechanisms of bacterial toxins, such as cholera toxin and heat-labile enterotoxin of Escherichia coli, are not entirely foreign to vertebrate cells.
Mono(ADP-ribosyl)ated proteins have been found in a variety of eukaryotic tissues (1) (2) (3) . These ADP-ribosylated proteins are present in practically every major compartment of the cell (4), suggesting a diversity of biological functions. However, little is known about the identity of these mono-(ADP-ribosyl)ated acceptor proteins and their physiological functions. Moss and Vaughn (5) have described a cytosolic ADP-ribosyltransferase from turkey erythrocytes that catalyzes the mono(ADP-ribosyl)ation of several endogenous proteins and the activation of brain adenylate cyclase. They were the first to suggest that the ADP-ribosyltransferase mechanisms of bacterial toxins, such as cholera toxin and heat-labile enterotoxin of Escherichia coli, are not entirely foreign to vertebrate cells.
The fragment A portion of diphtheria toxin and toxin A of Pseudomonas aeruginosa transfer ADP-ribose from NAD+ to the diphthamide acceptor site of elongation factor 2 (EF-2) (6) (7) (8) (9) (10) . ADP-ribosylated EF-2 no longer functions in protein synthesis, resulting in intoxication of the cells. In this paper we describe an endogenous mono(ADP-ribosyl)transferase from polyoma virus-transformed baby hamster kidney (pyBHK) cells that also transfers ADP-ribose from NAD+ to the diphthamide residue of EF-2.
MATERIALS AND METHODS
Enzymatic Activity. EF-2 was purified from pyBHK cells as described (11) . These EF-2 preparations also served as the source of the pyBHK transferase activity described in this report. Fragment A of diphtheria toxin was purified as described (12) . ADP-ribosyltransferase activity was measured by the incorporation of radioactivity from [adenosine-U-14C]NAD+ into trichloroacetic acid-precipitable material in the presence of EF-2 by a modification of a previously described procedure (11, 13) . The modification was the absence of histamine and the use of purified EF-2 in the reaction. Unless otherwise noted, the reaction was performed at 220C in 0. ,ug/ml and with or without various amounts of Pseudomonas toxin A, fragment A, or a mixture of fragment A and antifragment A antiserum. After various intervals of incubation, 10-,l samples were withdrawn and coprecipitated with 0.1 ml of bovine serum albumin at 0.1 mg/ml in 1 ml of 10% trichloroacetic acid. Precipitates were collected and washed, and the radioactivity was measured as described (11) .
Analysis of Reaction Product. Radiolabeled products formed in the ADP-ribosyltransferase assays were electrophoresed in NaDodSO4/polyacrylamide gels as described (11) . Gels were dried and developed by autoradiography (11) .
To determine if ADP-ribose was present in the acceptor protein as monomeric units or as poly(ADP-ribose), EF-2 was labeled by incubation for 160 min with [adenosine-U-14C]NAD' and the endogenous pyBHK transferase or fragment A as described for our standard reaction mixture. The reaction mixture was dialyzed extensively to remove NAD+, evaporated to dryness under nitrogen, and resuspended in 25 ,u of 20 mM ammonium bicarbonate buffer (pH 9.0). Then 25 ul of snake venom phosphodiesterase (Worthington) at 1 mg/ml in 40 mM MgCl2 was added (10) , and the mixture was incubated at 37°C for 15 min, 30 min, and 6 hr. The digested products were then chromatographed on thin-layer polyethyleneimine (PEI)-cellulose plates (J. T. Baker) with 0.3 M lithium chloride as the solvent (14) . AMP, adenosine, ADP-ribose, and NAD+ (Sigma) were cochromatographed as markers. The chromatogram was exposed to xray film (Kodak XRP-5) to locate the 14C-labeled products relative to the UV light-adsorbing markers. Radioactive material was scraped into vials and analyzed for radioactivity in a liquid scintillation spectrophotometer.
Reversal of the ADP-Ribosylation Reaction. Reverse reactions were done by incubating [U-14C]adenosine-labeled EF-2 at pH 6.6 with an excess of fragment A (10 jig/ml) and 2 mM nicotinamide at 22°C as described (7) . The radioactive products were analyzed by polyethyleneimine-cellulose thinlayer chromatography as described by Randerath and Randerath (15 NAD+ by fragment A or by the pyBHK endogenous transferase in the EF-2 preparations. EF-2 preparations were labeled as described in Fig. 1 , and the radioactive proteins were analyzed by electrophoresis on 12% NaDodSO4/polyacrylamide gels along with marker proteins. Lanes: right, fragment A-labeled EF-2; left, endogenous transferase-labeled EF-2. The radioactive proteins were visualized by autoradiography. The major band coelectrophoresed with the phosphorylase b marker with an Mr of 93,000, as does the major band of stained protein (11 22' taken, and trichloroacetic acidradioactivity.
mnous Transferase. Since large the transfer of label from NAD+ to EF-2 in a fragment Ant A were used routinely in our catalyzed reaction (Fig. 3A) . In fact, increasing the antibody to eliminate the possibility that concentration 5-fold provided similar results (data not accidentally contaminated with shown). The residual activity seen in the presence of antient A antibody greatly inhibited fragment A antiserum is presumably due to the endogenous transferase activity present in the EF-2 preparation. In contrast, the fragment A antibody had essentially no effect on the endogenous transferase of the EF-2 preparations (Fig.   A   3B ), indicating that this ADP-ribosyltransferase associated A with EF-2 is immunologically distinct from fragment A. Two other properties clearly distinguish the pyBHK endogenous transferase from the known ADP-ribosyltransferases that specifically modify EF-2. First, addition of a charcoal-adsorbed cytoplasmic extract from pyBHK cells to purified EF-2 inhibited the endogenous transferase activity from the EF-2 preparations by 90%o but had no effect on the ADP-ribosyltransferase activities of fragment A (Table 1) . However, boiling the cytoplasmic extract prior to use did destroy the inhibitory effect on the endogenous transferase activity from the EF-2 preparation. Second, 0.25 M histamine almost totally inhibited the activity of the endogenous ' ' ' transferase but had no appreciable effect on the activity of 80 120 160
either of the bacterial toxins ( (Fig. 4) . No radioactivity migrated with the marker ADP-ribose [which comigrates in the system with iso-ADP-ribose, the product of venom phosphodiesterase action on poly(ADP-ribose) (17) ]. Therefore, the ADPribose is present on the acceptor in EF-2 as monomeric units, rather than as poly(ADP-ribose). In addition, an extremely prolonged time of digestion (6 hr) resulted in the apparent conversion of [14C]AMP to a 14C-labeled material that comigrated with the adenosine marker (Fig. 4) . This apparent conversion of AMP to adenosine represents a trace of contaminant enzyme activity in the snake venom phosphodiesterase preparation. The ADP-ribosylation of EF-2 catalyzed by fragment A or Pseudomonas toxin A is reversible (7, 18, 19) . This reverse reaction requires excess toxin (i.e., fragment A) and nicotinamide and has a lower pH optimum than that of the forward Fig. 5 . A preparation of [14C]adenosine-labeled EF-2 containing a small amount of endogenous transferase (used in the forward reaction) was incubated in the absence or presence of excess fragment A and nicotinamide. Although little or no radioactivity was released from EF-2 in the absence of excess fragment A, over 60% of the radioactivity was released when both fragment A and nicotinamide were present in large excess. Similarly, radioactivity was released from EF-2 labeled in the forward reaction with fragment A and then reversed in the presence of excess fragment A and nicotinamide. The radioactive products of the reverse reactions were analyzed by thin-layer chromatography. The low molecular weight soluble products found in the reverse reaction mixtures had the chromatographic behavior of NAD' (Fig. 6 ). In addition, the reaction mixtures contained some labeled EF-2, which remained at the origin.
DISCUSSION
The mono(ADP-ribosyl)transferase from pyBHK cells can be distinguished from fragment A and Pseudomonas toxin A by the sensitivity of its activity to cytoplasmic extracts and to histamine. These properties may explain why similar cellular ADP-ribosyltransferases were not previously found by standard techniques. Crude preparations of EF-2 are commonly used to assay for fragment A and Pseudomonas toxin A, and histamine is commonly used to inhibit poly(ADP-ribosyl)transferase activity in reactions containing preparations of EF-2 (13). We observed that either condition inhibits the activity of the pyBHK ADP-ribosyltransferase. or the endogenous transferase in our standard reaction mixture. After exhaustive dialysis, which removes all unreacted NAD', the labeled proteins were incubated in Tris HCl buffer (pH 6.6) . For the reverse reaction, the EF-2 labeled by the endogenous transferase was incubated with fragment A (10 jig/ml) and 2 mM nicotinamide (e) or with 2 mM nicotinamide in the absence of fragment A (0). The fragment A-catalyzed forward reaction was also reversed with fragment A (10 Aig/ml) and 2 mM nicotinamide (A).
FIG. 6.
Thin-layer chromatography of the products formed by the reversal reaction. Radioactive compounds were visualized by autoradiography. EF-2 was radioactively labeled by fragment A or the endogenous ADP-ribosyltransferase from pyBHK cells as described in Fig. 1 . After extensive dialysis, the reaction was reversed as described in Fig. 5 . The products of the reversal were analyzed by chromatography on CEL-300 thin-layer plates with 0.3 M LiCl as eluent. Lanes: right, reversal products from EF-2 labeled in the presence of [adenosine-4C]NAD+ by fragment A; left, reversal products of EF-2 labeled by the endogenous transferase. Only the major radioactive product of the reversal had the same chromatographic mobility as NAD'. Radioactive EF-2 remains at the origin. No soluble radioactive labeled products were observed when labeled EF-2 from only the forward reaction was chromatographed.
The Rf values of NAD', AMP, and ADP-ribose are 0.79, 0.74, and 0.84, respectively. rations able to accept the transfer of ADP-ribose catalyzed by fragment A ranges from 43% to 90% (11) , with a typical preparation having about 50% ADP-ribosylatable EF-2. This variation in ADP-ribosylatable EF-2 may represent an inactivation of the acceptor activity during purification. We have shown that ADP-ribose acceptor activity of EF-2 is inactivated by both freezing and thawing samples and by prolonged storage at -20 or -70'C (unpublished observations). Alternative explanations for the reduced acceptor activity of our EF-2 preparations are the presence of ADP-ribosylated EF-2 in EF-2 preparations extracted from cells or protein contaminants in our EF-2 preparations. The former explanation assumes that EF-2 is normally ADP-ribosylated in pyBHK cells and copurifies with EF-2. Fragment A and Pseudomonas toxin A transfer ADP-ribose from NAD' specifically to the diphthamide acceptor site of EF-2 (6, 9, 10) . Diphthamide is a unique, modified histidine residue only found in EF-2 (9, 10). This residue apparently has been conserved throughout eukaryotic evolution (18, 20, 21) Using identical methods to those reported here, we have isolated a cellular ADP-ribosyltransferase from beef liver, which is also a mono(ADP-ribosyl)transferase that transfers ADP-ribose from NAD' to diphthamide of liver EF-2 (unpublished data). Thus, this enzyme activity can also be found in normal tissues from a different species and, therefore, may be ubiquitous.
To fully understand the reaction catalyzed by the pyBHK ADP-ribosyltransferase, a defined system containing purified enzyme, substrate, and inhibitor must be established. In addition, this enzyme system should be shown to be operative in vivo in several cell types.
